TD Asset Management
BIVV

TD Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

TD Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-143,115
Closed -$7.72M – 1397
2017
Q4 		$7.72M Buy
143,115
+35,732
+33% +$1.96M 0.01% 582
2017
Q3 		$6.13M Buy
107,383
+41,300
+62% +$2.42M 0.01% 616
2017
Q2 		$3.98M Buy
66,083
+39,421
+148% +$2.24M 0.01% 723
2017
Q1 		$1.45M Buy
+26,662
New +$1.31M ﹤0.01% 954

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

TD Asset Management's BIVV Position: Q1 2018 in Review

TD Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 143,115 shares — an estimated $7.72M sold.

TD Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $7.72M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • TD Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • TD Asset Management sold 143,115 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $7.72M.
  • TD Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • TD Asset Management's Bioverativ Inc. Common Stock position peaked at $7.72M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on TD Asset Management's 13F filing for Q1 2018, filed 11 May 2018.